Specifically, the overexpression of TFB2M in ovarian cancer is negatively correlated with the survival rate of ovarian cancer patients and moderately positively correlated with tumor-associated macrophage (TAM) infiltration [12]. The gene discussed is TFB2M; the disease is ovarian carcinoma.